Laurion Capital Management LP Uro Gen Pharma Ltd. Transaction History
Laurion Capital Management LP
- $8.4 Billion
- Q2 2024
A detailed history of Laurion Capital Management LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Laurion Capital Management LP holds 160,600 shares of URGN stock, worth $2.04 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
160,600
Previous 250,600
35.91%
Holding current value
$2.04 Million
Previous $3.76 Million
28.33%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding URGN
# of Institutions
119Shares Held
39.3MCall Options Held
158KPut Options Held
161K-
Rtw Investments, LP New York, NY3.56MShares$45.2 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.3MShares$41.9 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$39.2 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.91MShares$36.9 Million12.93% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$31.1 Million0.11% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $289M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...